Brain metastases represent a growing healthcare challenge with a rising incidence attributed to earlier detection and improved systemic cancer treatments. We conducted a systematic review and meta-analysis to investigate the local recurrence rate following surgical resection of a brain metastasis without adjuvant therapy. The analysis included four studies with a total of 235 cases. It was found that the rate of local recurrence by 12-months was 48.1% (95% CI 41.2-58.9). These findings underscore the high rate of patients who will experience local recurrence within 12-months of surgery, emphasising the need for vigilant surveillance when omitting adjuvant radiotherapy in favour of systemic treatments with potential but unproven CNS penetrance. The analysis highlights unmet needs in this patient population.
Keyphrases
- healthcare
- free survival
- brain metastases
- early stage
- small cell lung cancer
- resting state
- minimally invasive
- public health
- white matter
- radiation therapy
- risk factors
- squamous cell carcinoma
- functional connectivity
- papillary thyroid
- multiple sclerosis
- coronary artery disease
- blood brain barrier
- coronary artery bypass
- acute coronary syndrome
- climate change
- atrial fibrillation
- brain injury
- young adults
- rectal cancer
- real time pcr